Related Experiment Video
Updated: Jun 7, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
147
Long non-coding RNAs in pancreatic cancer
Yuan Chen1, Xiaohua Ye1, Minli Hu1
1Department of Gastroenterology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, Zhejiang, China.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|November 13, 2024
Summary
This review highlights advances in pancreatic cancer research, focusing on long non-coding RNAs (lncRNAs) and their role in disease progression. Understanding lncRNAs offers new diagnostic and therapeutic strategies for this deadly cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic cancer is a deadly disease with late diagnosis and rapid invasion.
- Early detection and prevention are crucial for improving patient survival rates.
- Long non-coding RNAs (lncRNAs) play significant roles in physiological and pathological processes, including cancer development.
Purpose of the Study:
- To review recent advancements in pancreatic cancer pathogenesis, diagnosis, and treatment.
- To explore the relationship between lncRNAs and pancreatic cancer progression.
- To provide insights into the diagnostic and therapeutic potential of lncRNAs in pancreatic cancer.
Main Methods:
- Literature review of recent studies on pancreatic cancer.
- Analysis of the biological functions and expression patterns of lncRNAs.
- Evaluation of the clinical significance and targeted therapy potential of lncRNAs.
Main Results:
- LncRNAs are implicated in tumor growth, differentiation, and proliferation in pancreatic cancer.
- Altered lncRNA expression patterns are observed in pancreatic cancer.
- LncRNAs show potential as biomarkers for early detection and as targets for novel therapies.
Conclusions:
- LncRNAs represent a promising area for developing new diagnostic and therapeutic strategies for pancreatic cancer.
- Further research into lncRNA functions can lead to improved prevention and treatment approaches.
- Targeting lncRNAs may offer novel avenues for combating pancreatic cancer.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:20Types of RNA
5.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.7K
03:18Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:54Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K